Search

Your search keyword '"Wong, Steven H."' showing total 144 results
Start Over Author "Wong, Steven H."
144 results on '"Wong, Steven H."'

3. From Personalized Medicine to Personalized Justice: The Promises of Translational Pharmacogenomics in the Justice System

Author

Wong, Steven H. Y., Happy, Christopher, Blinka, Daniel, Goch, Suson, Jensen, Jeffrey M., Donald, Joseph M., Coleman, Howard, Jortani, Saeed A., Lurie, Yolanda, Morris-Kukoski, Cynthia L., Newman, Manuela G., Orsulak, Paul J., Sander, Tara, Wagner, Michael A., Wynn, Jennifer R., Wu, Alan H. B., Yeo, Kiang-Teck J., Wu, Alan H. B., editor, and Yeo, Kiang-Teck J., editor

Published
2011
Full Text
View/download PDF

7. From Personalized Medicine to Personalized Justice: The Promises of Translational Pharmacogenomics in the Justice System

Author

Wong, Steven H. Y., primary, Happy, Christopher, additional, Blinka, Daniel, additional, Goch, Suson, additional, Jensen, Jeffrey M., additional, Donald, Joseph M., additional, Coleman, Howard, additional, Jortani, Saeed A., additional, Lurie, Yolanda, additional, Morris-Kukoski, Cynthia L., additional, Newman, Manuela G., additional, Orsulak, Paul J., additional, Sander, Tara, additional, Wagner, Michael A., additional, Wynn, Jennifer R., additional, Wu, Alan H. B., additional, and Yeo, Kiang-Teck J., additional

Published
2010
Full Text
View/download PDF

16. Recommendations for the Generation, Quantification, Storage, and Handling of Peptides Used for Mass Spectrometry–Based Assays

Author

Hoofnagle, Andrew N, primary, Whiteaker, Jeffrey R, primary, Carr, Steven A, primary, Kuhn, Eric, primary, Liu, Tao, primary, Massoni, Sam A, primary, Thomas, Stefani N, primary, Townsend, R Reid, primary, Zimmerman, Lisa J, primary, Boja, Emily, primary, Chen, Jing, primary, Crimmins, Daniel L, primary, Davies, Sherri R, primary, Gao, Yuqian, primary, Hiltke, Tara R, primary, Ketchum, Karen A, primary, Kinsinger, Christopher R, primary, Mesri, Mehdi, primary, Meyer, Matthew R, primary, Qian, Wei-Jun, primary, Schoenherr, Regine M, primary, Scott, Mitchell G, primary, Shi, Tujin, primary, Whiteley, Gordon R, primary, Wrobel, John A, primary, Wu, Chaochao, primary, Ackermann, Brad L, primary, Aebersold, Ruedi, primary, Barnidge, David R, primary, Bunk, David M, primary, Clarke, Nigel, primary, Fishman, Jordan B, primary, Grant, Russ P, primary, Kusebauch, Ulrike, primary, Kushnir, Mark M, primary, Lowenthal, Mark S, primary, Moritz, Robert L, primary, Neubert, Hendrik, primary, Patterson, Scott D, primary, Rockwood, Alan L, primary, Rogers, John, primary, Singh, Ravinder J, primary, Van Eyk, Jennifer E, primary, Wong, Steven H, primary, Zhang, Shucha, primary, Chan, Daniel W, primary, Chen, Xian, primary, Ellis, Matthew J, primary, Liebler, Daniel C, primary, Rodland, Karin D, primary, Rodriguez, Henry, primary, Smith, Richard D, primary, Zhang, Zhen, primary, Zhang, Hui, primary, and Paulovich, Amanda G, primary

Published
2016
Full Text
View/download PDF

17. A New Look at Trigger Point Injections

Author

Wong, Clara S. M. and Wong, Steven H. S.

Subjects
Article Subject
Abstract

Trigger point injections are commonly practised pain interventional techniques. However, there is still lack of objective diagnostic criteria for trigger points. The mechanisms of action of trigger point injection remain obscure and its efficacy remains heterogeneous. The advent of ultrasound technology in the noninvasive real-time imaging of soft tissues sheds new light on visualization of trigger points, explaining the effect of trigger point injection by blockade of peripheral nerves, and minimizing the complications of blind injection.

Published
2012
Full Text
View/download PDF

36. Pharmacogenomics and Personalized Medicine.

Author

Dasgupta, Amitava and Wong, Steven H. Y.

Abstract

With the completion of the human genome project, pharmacogenomics is regarded as part of genomic medicine and personalized medicine. While pharmacogenomics is concerned with the whole genome effect on drug metabolism and efficacy, pharmacogenetics is readily defined as the study of the genetic effect, for example, single-nucleotide polymorphism, on an individual's ability to metabolize a drug or compound. Pharmacogenomic biomarkers, in combination with other biomarkers, enable personalized medicine by identifying the right patient, with the right diagnosis/treatment, matching with the right drug, the right dose and at the right time, thus achieving clinical efficacy with no or minimized toxicity. This chapter would attempt to present pharmacogenomics, not only as an emerging, inter-dependent discipline, but as a complementing field in enhancing drug therapy. It includes the introduction, the pharmacogenomics space and the enabling drivers, the principles of pharmacogenetics/pharmacogenomics, with update on the candidate pharmacogenomics testing. Recent examples would include warfarin and irinotecan, showing that pharmacogenomic biomarkers would serve as adjuncts to other functional biomarkers for enhanced drug therapy. [ABSTRACT FROM AUTHOR]

Published
2008
Full Text
View/download PDF

41. Consensus Document: Therapeutic Monitoring of Tacrolimus (FK-506)

Author

Jusko, William J., primary, Thomson, Angus W., additional, Fung, John, additional, McMaster, Paul, additional, Wong, Steven H., additional, Zylber-Katz, Ester, additional, Christians, Uwe, additional, Winkler, Michael, additional, Fitzsimmons, William E., additional, Lieberman, Ronald, additional, McBride, James, additional, Kobayashi, Masakazu, additional, Warty, Vijay, additional, and Soldin, Steven J., additional

Published
1995
Full Text
View/download PDF

45. Pharmacogenomics as an Aspect of Molecular Autopsy for Forensic Pathology/Toxicology: Does Genotyping CYP 2D6 Serve as an Adjunct for Certifying Methadone Toxicity?

Author

Wong, Steven H., Wagner, Michael A., Jentzen, Jeffrey M., Schur, Chuck, Bjerke, Jeanette, Gock, Susan B., and Chang, Chung-Che

Subjects
*METHADONE hydrochloride, *DRUG side effects, *CYTOCHROME P-450, *FORENSIC pathology, *FORENSIC toxicology
Abstract

Examines the hypothesis that methadone fatality as an adverse drug reaction may be attributed partly to the cytochrome P-450 2D6 variant alleles encoding for enzymes with resultant poor metabolism of methadone and other drugs. Review of methadone cases as part of the opioids deaths between 1998 and 2000; Molecular autopsy; Pharmacogenomics.

Published
2003
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results